US87807D4007 - TCBP - A3E2F4 (XNCM)
TC BIOPHARM(H.)SP. ADS/20 Depository Receipt
0,62 EUR
Current Prices from TC BIOPHARM(H.)SP. ADS/20
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NASDAQ |
TCBP
|
USD
|
23.12.2024 21:07
|
0,64 USD
| 0,67 USD | -3,67 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-0,68 % | 18,47 % | 3,59 % | -88,82 % | -92,40 % | -97,22 % | -100,00 % |
Company Profile for TC BIOPHARM(H.)SP. ADS/20 Depository Receipt
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Company Data TC BIOPHARM(H.)SP. ADS/20 Depository Receipt
Name TC BIOPHARM(H.)SP. ADS/20
Company TC Biopharm (Holdings) Plc
Symbol TCBP
Website https://www.tcbiopharm.com
Primary Exchange
Frankfurt
WKN A3E2F4
ISIN US87807D4007
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Mr. Bryan Leland Kobel
Country United Kingdom
Currency EUR
Employees 0,0 T
Address Maxim 1, ML1 4WR Motherwell
IPO Date 2022-02-11
Aktien-Splits
Datum | Split |
---|---|
05.08.2024 | 1:10 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | T0U.F |
NASDAQ | TCBP |
Weitere Aktien
Investoren die TC BIOPHARM(H.)SP. ADS/20 die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.